Finance committee  In this case, the calculation is based on 60 companies, 20%. That would be $60 million, if we look at the amount of research invested by these 60 biotech companies in Canada.

Finance committee  It represents $60 million.

Finance committee  On a yearly basis.

Finance committee  Absolutely, last October 4.

Finance committee  In Europe it is 10 years, and in Japan it is 10 years.

Finance committee  Eight years. We are in line now, finally.

Finance committee  In fact, on the biotech sector?

Finance committee  As public companies, we would like to be treated the same as the private companies under Canadian control, which have taxable revenues of less than $200,000. So these credits will be refundable, as they are in some provinces.

Finance committee  I can tell you that without the tax incentives, the research level would probably be lower than it is now. Tax incentives make up one component of the attractiveness of Canada as a competitor on a worldwide basis. Of course, intellectual property is a very important component as

Finance committee  This is extremely important. This is for the patients. For example, six months ago I imported a compound from Germany...I was hoping this data protection would be put in place. In fact, it was put in place, and I was asked for collaboration from Indian and Chinese companies. I ha

Finance committee  On this question, I would like the help of Brigitte Nolet.

Finance committee  In fact, the issue of data protection is the first stage we need to pass to become globally competitive and to attract investment. As for profits, in the field of biopharmaceuticals, I am only experiencing losses; I am not making any profits. I am referring to my own company. So

Finance committee  The member companies of Rx&D invest $1.1 billion per year in innovative research in Canada. When we talk about me-too drugs, you are talking about generic products. I do not believe that a discovery like insulin would be part of that group.

Finance committee  Insulin was discovered in Canada. Some anti-psychotics and products to control schizophrenia were also discovered in Canada. SINGULAIR, by Merck Frosst, was also discovered in Canada. These are great innovations. Therefore, the research companies who are members of Rx&D repr

Finance committee  Thank you very much, Mr. Chairman. I would like to extend a warm hello to you and to all members of the committee, and to thank you for giving us the opportunity to address you today on behalf of Rx&D, the association representing Canada's Research-Based Pharmaceutical Comp